Skip to content
Use caution Drug recall · FDA · Published May 16, 2014

Actavis Recalls Vancomycin Capsules Due to Subpotency

Actavis recalls 6,913 packages of Vancomycin Hydrochloride Capsules (250 mg) due to subpotent drug issues. Check lot numbers and expiry dates.

🇺🇸 FDA recall #D-1386-2014DrugActavis ›
Take action

Contact the company

Recalling firmActavis Inc400 Interpace Pkwy · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

What happened, in plain English

Actavis Inc is recalling Vancomycin Hydrochloride Capsules, USP, 250 mg because the drug may be subpotent. The affected product consists of 20 capsules on 2 x 10 capsule blister cards. This recall involves 6,913 packages distributed nationwide in the U.S. Read more at govinfonow.com/recall/46037-actavis-inc-recalls-vancomycin-hydrochloride-capsules-usp-250-mg-20.

Source Summary by GovInfoNow · govinfonow.com/recall/46037-actavis-inc-recalls-vancomycin-hydrochloride-capsules-usp-250-mg-20 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1386-2014

Cite this page

“Actavis Recalls Vancomycin Capsules Due to Subpotency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/46037-actavis-inc-recalls-vancomycin-hydrochloride-capsules-usp-250-mg-20. Based on FDA recall #D-1386-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1386-2014%22&limit=1).

Why it’s dangerous

The hazard is described as a 'Subpotent Drug,' meaning the capsules may contain less active ingredient than labeled. This can result in inadequate treatment for bacterial infections, potentially allowing the infection to persist or worsen because the medication is not working as intended.

Who’s affected

Patients who have been prescribed Vancomycin Hydrochloride Capsules, USP, 250 mg by a healthcare provider are likely affected. Individuals who purchased or were dispensed this specific medication between its manufacture and the recall date are at risk of receiving subpotent doses.

How to tell if you have this one

Look for Vancomycin Hydrochloride Capsules, USP, 250 mg packaged as 20 capsules on 2 x 10 capsule blister cards. Check for NDC 0591-3561-15 and Lot # 3100135 with an expiry date of 05/2014. The product was manufactured by Patheon Pharmaceuticals Inc. for Watson Pharma Inc.

  • Brand
    Actavis
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Your Pharmacist

    Reach out to the pharmacy where you filled your prescription to determine if your specific lot is part of this recall.

  2. Do Not Stop Medication Without Advice

    Consult your healthcare provider before making any changes to your medication regimen, as they can advise on alternative treatments or replacements.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: May 16, 201412. FDA classified it Class II: Jun 17, 201423. Published in FDA’s Enforcement Report: Jun 25, 201434. FDA terminated the recall: Feb 23, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1386-2014 (May 16, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1386-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA